SCNX
What one share of Scienture Holdings holds
Pharmaceutical Preparations
Scienture Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.03 |
|---|---|
| Profit | −$1.30 |
| Cash and investments | $0.20 |
| Debt | $0.05 |
| Book value | $1.56 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2013 | $6.10 | −$13.35 | $0.07 | −$5.46 | — | — |
| 2014 | $4.51 | −$6.30 | — | −$3.21 | — | $1.92 |
| 2015 | $8.37 | −$3.60 | — | $0.26 | — | $0.76 |
| 2016 | $7.08 | −$7.87 | — | −$1.44 | — | −$3.26 |
| 2017 | $7.74 | $0.90 | — | $0.45 | — | −$0.88 |
| 2019 | $18.81 | −$0.75 | — | $0.36 | — | $9.50 |
| 2020 | $33.33 | −$4.94 | $0.07 | −$4.38 | — | $16.09 |
| 2021 | $18.23 | −$9.80 | $0.04 | −$4.77 | — | $6.92 |
| 2022 | $18.09 | −$6.13 | — | −$2.69 | — | $1.22 |
| 2023 | $0.57 | −$23.35 | — | −$0.93 | — | — |
| 2024 | $0.04 | $2.48 | $0.00 | −$3.91 | — | — |
| 2025 | $0.03 | −$2.70 | — | −$0.87 | — | $1.73 |